## Investigation of Choice: Cardiac MRI **Key Point:** Cardiac MRI with T1 mapping and late gadolinium enhancement (LGE) is the gold standard for characterizing left ventricular hypertrophy (LVH) and detecting myocardial fibrosis, the pathological hallmark of hypertensive heart disease. ### Why Cardiac MRI is Superior Cardiac MRI provides: - **Precise quantification** of LV wall thickness and mass (gold standard) - **Tissue characterization** via T1 mapping to detect diffuse fibrosis - **Late gadolinium enhancement** to identify focal scar and replacement fibrosis - **Assessment of diastolic dysfunction** through strain imaging - **Prognostic information** — presence of fibrosis predicts adverse outcomes **High-Yield:** In chronic hypertension, the cellular adaptation is **concentric hypertrophy** (increased wall thickness, normal or reduced cavity size). This leads to diastolic dysfunction and eventually systolic dysfunction if the stimulus persists. MRI detects both the hypertrophy and the accompanying interstitial and replacement fibrosis that drives functional deterioration. ### Comparison with Other Modalities | Investigation | Detects Hypertrophy | Detects Fibrosis | Functional Assessment | Specificity | |---|---|---|---|---| | **Cardiac MRI** | ✓✓ (gold standard) | ✓✓ (T1, LGE) | ✓✓ (strain, EF) | Highest | | Echocardiography | ✓ (operator-dependent) | ✗ | ✓ (EF, diastolic parameters) | Moderate | | ECG | ✓ (voltage criteria) | ✗ | ✗ | Low (many false positives) | | Chest X-ray | ✗ (indirect only) | ✗ | ✗ | Very low | **Clinical Pearl:** The presence of myocardial fibrosis on MRI in hypertensive LVH is an independent predictor of sudden cardiac death and heart failure progression, making it crucial for risk stratification. **Mnemonic: MRI for Myocardial characterization and Risk stratification in Hypertensive heart disease — "MRI-RH"** 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.